What women with ovarian cancer think and know about genetic testing
- 1 October 2008
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 111 (1), 132-136
- https://doi.org/10.1016/j.ygyno.2008.06.016
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Increased Uptake ofBRCA1/2Genetic Testing Among African American Women With a Recent Diagnosis of Breast CancerJournal of Clinical Oncology, 2008
- Society of Gynecologic Oncologists Education Committee Statement on Risk Assessment for Inherited Gynecologic Cancer Predispositions☆Gynecologic Oncology, 2007
- Barriers to participating in genetic counseling and BRCA testing during primary treatment for breast cancerGenetics in Medicine, 2007
- The Role of Financial Factors in Acceptance of Clinical BRCA Genetic TestingGenetic Testing, 2007
- PARP-1 inhibitors: are they the long-sought genetically specific drugs for BRCA1/2-associated breast cancers?International Journal of Medical Sciences, 2006
- BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma casesCancer, 2005
- Testing the construct validity of willingness to pay valuations using objective information about risk and health benefitHealth Economics, 2005
- Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategyNature, 2005
- Prevalence and Penetrance of Germline BRCA1 and BRCA2 Mutations in a Population Series of 649 Women with Ovarian CancerAmerican Journal of Human Genetics, 2001